ACTIVE

PRODIVET PHARMACEUTICALS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result101,4 k €-59,6 %over 1 year

Gross margin861,9 k €-20,3 %over 1 year

Equity2,8 M €+3,7 %over 1 year

Workforce8,6 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

PRODIVET PHARMACEUTICALS is a Public limited company incorporated in 1983. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Raeren. It employs on average 8,6 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0423.519.816
Incorporation: 18/01/1983
Legal form: Public limited company
Registered office: Hagbenden 39C
4731 Raeren · WallonieSee on map
Contributed capital: 101 520,00 €
Latest accounts: 31/12/2025
Average workforce: 8,6 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores 47740Retail sale of medical and orthopaedic goods in specialised stores+3

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	861,9 k €	-20.3%	1,1 M €	+12.7%	959,8 k €	-6.9%	1 M €	-9.3%	1,1 M €
EBITDA	274,4 k €	-43.4%	485,1 k €	+43.1%	339,1 k €	-34.6%	518,2 k €	-8.1%	564,1 k €
Operating result	154,4 k €	-59.4%	380 k €	+50.7%	252,2 k €	-43.7%	448,3 k €	-11.9%	508,7 k €
Net result	101,4 k €	-59.6%	251,1 k €	+71.5%	146,4 k €	-65.7%	426,6 k €	-0.9%	430,3 k €
Balance sheet
Equity	2,8 M €	+3.7%	2,7 M €	+10.2%	2,5 M €	+6.3%	2,3 M €	+13.6%	2 M €
Total assets	3,3 M €	+5.0%	3,2 M €	+6.6%	3 M €	-6.3%	3,2 M €	+10.6%	2,9 M €
Cash	1,4 M €	+11.9%	1,2 M €	+9.9%	1,1 M €	-32.2%	1,7 M €	-7.6%	1,8 M €
Debts	493,9 k €	+13.8%	433,9 k €	-11.6%	490,9 k €	-41.5%	838,6 k €	+3.0%	813,8 k €
Other
Workforce	8,6 ETP	0.0%	8,6 ETP	-9.5%	9,5 ETP	+4.4%	9,1 ETP	-15.7%	10,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Dorothea HICK-ROX	Director15/05/2005 → 26/12/2029
HEDO0433.720.256Represented by Herbert OSSEMANN	Managing director01/05/2015 → 26/12/2029Director15/05/2005 → 2014 accountsended
Yves OSSEMANN	Managing director01/05/2015 → 26/12/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Herbert OSSEMANN	Chairman of the board of directors01/05/2015 → 2019 accountsManaging director06/05/2011 → 2014 accounts
Dorothea HICK - ROX	Director15/05/2005 → 2010 accounts

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/05/2026	20/06/2025	24/06/2024	02/06/2023	28/06/2022	30/08/2021
General meeting	04/05/2026	23/05/2025	24/05/2024	05/05/2023	27/05/2022	07/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	04/05/2026	29/05/2026	German	PDF
Abridged model	31/12/2024	23/05/2025	20/06/2025	German	PDF
Abridged model	31/12/2023	24/05/2024	24/06/2024	German	PDF
Abridged model	31/12/2022	05/05/2023	02/06/2023	German	PDF
Abridged model	31/12/2021	27/05/2022	28/06/2022	German	PDF
Abridged model	31/12/2020	07/05/2021	30/08/2021	German	PDF
Abridged model	31/12/2019	04/05/2020	29/10/2020	German	PDF
Abridged model	31/12/2018	24/05/2019	30/08/2019	German	PDF
Abridged model	31/12/2017	25/05/2018	30/08/2018	German	PDF
Abridged model	31/12/2016	26/05/2017	27/06/2017	German	PDF
Abridged model	31/12/2015	06/05/2016	31/08/2016	German	PDF
Abridged model	31/12/2014	01/05/2015	24/08/2015	German	PDF
Abridged model	31/12/2013	02/05/2014	14/08/2014	German	PDF
Abridged model	31/12/2012	03/05/2013	29/08/2013	German	PDF
Abridged model	31/12/2011	04/05/2012	31/08/2012	German	PDF
Abridged model	31/12/2010	06/05/2011	31/08/2011	French	PDF
Abridged model	31/12/2009	07/05/2010	12/08/2010	French	PDF
Abridged model	31/12/2008	04/05/2009	31/08/2009	German	PDF
Abridged model	31/12/2007	02/05/2008	30/07/2008	German	PDF
Abridged model	31/12/2006	04/05/2007	31/07/2007	German	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Dorothea HICK-ROX	Director15/05/2005 → 26/12/2029
HEDO0433.720.256Represented by Herbert OSSEMANN	Managing director01/05/2015 → 26/12/2029Director15/05/2005 → 2014 accountsended
Yves OSSEMANN	Managing director01/05/2015 → 26/12/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Herbert OSSEMANN	Chairman of the board of directors01/05/2015 → 2019 accountsManaging director06/05/2011 → 2014 accounts
Dorothea HICK - ROX	Director15/05/2005 → 2010 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates01/02/2024
SATZUNGEN (UEBERSETZUNG, KOORDINATION, ANDERE AENDERUNGEN, ) - VERSCHIEDENES - KAPITAL - AKTIEN - ENTLASSUNG - ERNENNUNG
PDF
Mandates18/10/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates17/12/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates10/11/2016
Prolongation de mandats et nomination
PDF
Mandates20/02/2012
DENOMINATION - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates01/09/2011
DEMISSIONS, NOMINATIONS
PDF
Mandates15/12/2005
ENTLASSUNG - ERNENNUNG
PDF
Other08/07/2004
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

HEDO

Yves OSSEMANN

Dorothea HICK-ROX

Herbert OSSEMANN

Dorothea HICK - ROX

19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

PRODIVET

Hagbenden 39 C, 4731 Eynatten

Managing directorDirector

Managing director

Director

Chairman of the board of directorsManaging director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Hagbenden 39C, 4731 EynattenCurrent		CBE
Hagbenden 39 C, 4731 Eynatten	accounts 2021 → 2025	Accounts 2025 · 2026-00125661

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
PRODIVET PHARMACEUTICALSCurrent		CBE
PRODIVET	accounts 2021 → 2025	Accounts 2025 · 2026-00125661

Events

2025
Annual accounts 2025101,4 k €↓
2024
Annual accounts 2024251,1 k €↑
2023
Annual accounts 2023146,4 k €↓
2022
Annual accounts 2022426,6 k €↓
2021
Annual accounts 2021430,3 k €↑
2020
Annual accounts 2020398,2 k €↑
2019
Annual accounts 2019246,1 k €↓
2018
Annual accounts 2018352,1 k €↑
2017
Annual accounts 2017340,4 k €↑
2016
Annual accounts 2016203,4 k €↑
2015
Annual accounts 2015187,7 k €↓
2014
Annual accounts 2014267,8 k €↑
2013
Annual accounts 201385,1 k €↑
2012
Annual accounts 201249,1 k €↓
2011
Annual accounts 201168,9 k €↓
2010
Annual accounts 201093,2 k €↑
2009
Annual accounts 200960,2 k €↓
2008
Annual accounts 2008116,5 k €↓
2007
Annual accounts 2007295 k €↑
2006
Annual accounts 200611,1 k €
18/01/1983
IncorporationPublic limited company

PRODIVET PHARMACEUTICALS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events